Navid Alipour is the CEO and co-founder of CureMetrix and CureMatch. CureMetrix, a global leader in artificial intelligence for medical imaging with a women's health focus, is the first and only FDA-cleared AI for detecting breast arterial calcification in women, from the same mammogram used to detect breast cancer.

CureMatch focuses on personalized medicine and combination therapy in oncology. Through the founding of Analytics Ventures, an AI-focused VC fund, and multiple companies, Navid focuses on the convergence of AI and the life sciences to prolong lives and save lives.

Navid serves on several boards, including Tech San Diego, CureMetrix, CureMatch, and Praxis Solutions. He is a sought-after panelist, judge, speaker, and moderator on the topics of venture capital, artificial intelligence, healthcare, and entrepreneurship. Navid holds a BA from UC San Diego and a JD/MBA from the University of San Diego.